WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / October 2025 / K251331

510(k) cleared

Blood Pressure Monitor (B73, BE23T)

Shenzhen Jamr Technology Co., Ltd. · Oct 27, 2025 · K251331

FDA cleared the Blood Pressure Monitor (B73, BE23T) from Shenzhen Jamr Technology Co., Ltd. on Oct 27, 2025 under K251331, a traditional 510(k). The device falls under product code DXN, System, Measurement, Blood-Pressure, Non-Invasive, regulated at 21 CFR 870.1130 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Apr 30, 2025. The decision came 180 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Shenzhen Jamr Technology Co., Ltd. has one other decision in the tracker over the last 12 months: K253570 (Blood Pressure Monitor (W06LT)).

Questions & Answers

What did FDA clear under K251331?

K251331 is the FDA 510(k) for Blood Pressure Monitor (B73, BE23T), submitted by Shenzhen Jamr Technology Co., Ltd.. FDA's decision date was Oct 27, 2025, under product code DXN (System, Measurement, Blood-Pressure, Non-Invasive).

Who makes the Blood Pressure Monitor (B73, BE23T)?

Shenzhen Jamr Technology Co., Ltd., based in Shenzhen, is the applicant of record for K251331.

How long did the K251331 review take?

FDA received the submission on Apr 30, 2025 and issued its decision on Oct 27, 2025, 180 days later.

← All decisions in October 2025

Sources